Search research articles
Contact Us
Filters
Showing results (91-100 of 135) with videos related to
Page
of 14
Sort By:
NPJ Vaccines
|
February 17, 2024
Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets
In-Jeong Kim, Olga Gonzalez, Michael P Tighe, et al.
Journal of Virology
|
October 27, 2021
Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques
Jingyou Yu, Natalie D Collins, Noe B Mercado, et al.
The Lancet. Infectious Diseases
|
August 17, 2024
Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trial
Kayvon Modjarrad, Paul T Scott, Melanie McCauley, et al.
Nature Communications
|
December 5, 2025
Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines
Wei Chen, Kristin R Tompkins, Ian W Windsor, et al.
Nature Communications
|
July 29, 2015
Evaluation of candidate vaccine approaches for MERS-CoV
Lingshu Wang, Wei Shi, M Gordon Joyce, et al.
NPJ Vaccines
|
March 19, 2023
SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies
Shikha Shrivastava, Joshua M Carmen, Zhongyan Lu, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
May 2, 2024
Clinical, molecular, and drug resistance epidemiology of HIV in Jordan, 2019-2021: A national study
Faris G Bakri, Heyam H Mukattash, Hiam Esmeiran, et al.
The Journal of Infectious Diseases
|
May 11, 2022
Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019
Shilpa Hakre, Ines Lakhal-Naouar, David B King, et al.
The Lancet. Infectious Diseases
|
June 30, 2023
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial
Michael A Koren, Leyi Lin, Kenneth H Eckels, et al.
The Lancet. Microbe
|
May 18, 2024
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
Brittany L Ober Shepherd, Paul T Scott, Jack N Hutter, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 135) with videos related to
Sort By:
Page
of 14
NPJ Vaccines
|
February 17, 2024
Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets
In-Jeong Kim, Olga Gonzalez, Michael P Tighe, et al.
Journal of Virology
|
October 27, 2021
Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques
Jingyou Yu, Natalie D Collins, Noe B Mercado, et al.
The Lancet. Infectious Diseases
|
August 17, 2024
Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trial
Kayvon Modjarrad, Paul T Scott, Melanie McCauley, et al.
Nature Communications
|
December 5, 2025
Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines
Wei Chen, Kristin R Tompkins, Ian W Windsor, et al.
Nature Communications
|
July 29, 2015
Evaluation of candidate vaccine approaches for MERS-CoV
Lingshu Wang, Wei Shi, M Gordon Joyce, et al.
NPJ Vaccines
|
March 19, 2023
SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies
Shikha Shrivastava, Joshua M Carmen, Zhongyan Lu, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
May 2, 2024
Clinical, molecular, and drug resistance epidemiology of HIV in Jordan, 2019-2021: A national study
Faris G Bakri, Heyam H Mukattash, Hiam Esmeiran, et al.
The Journal of Infectious Diseases
|
May 11, 2022
Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019
Shilpa Hakre, Ines Lakhal-Naouar, David B King, et al.
The Lancet. Infectious Diseases
|
June 30, 2023
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial
Michael A Koren, Leyi Lin, Kenneth H Eckels, et al.
The Lancet. Microbe
|
May 18, 2024
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
Brittany L Ober Shepherd, Paul T Scott, Jack N Hutter, et al.
Page
of 14